Small Canadian firm hopeful for U.S. flu vaccine contract next year

02/23/2005 | Reuters

ID Biomedical may not be able to sell its flu vaccine to the U.S. in time for the current season or for the 2005-2006 season, but CEO Tony Holler said he is optimistic the firm will get approval to supply Fluviral for the 2006-2007 flu season. The FDA still needs to inspect the company's facilities and approve its proposals for clinical trials for its vaccine.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ